MINI REVIEW article

Front. Neurol.

Sec. Neurotrauma

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1617126

Meningeal enhancement following traumatic brain injury: a mini review

Provisionally accepted
Alejandro  Arbona-LampayaAlejandro Arbona-Lampaya1*Alejandro  Odeh-CouvertierAlejandro Odeh-Couvertier1Ricardo  Sanchez-JimenezRicardo Sanchez-Jimenez2Eduardo  Labat-AlvarezEduardo Labat-Alvarez2
  • 1University of Puerto Rico - School of Medicine, San Juan, Puerto Rico
  • 2Department of Radiology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico

The final, formatted version of the article will be published soon.

Traumatic brain injury (TBI) is a significant cause of neurological morbidity, often leading to bloodbrain barrier (BBB) dysfunction and secondary injury mechanisms. Recent advancements in neuroimaging have highlighted traumatic meningeal enhancement (TME) on contrast-enhanced fluidattenuated inversion recovery (FLAIR) MRI as a promising biomarker for detecting BBB disruption following TBI. TME, which is hypothesized to arise from vascular injury and inflammatory cascades that compromise the blood-meningeal barrier, has been associated with both acute trauma and longterm neurovascular dysfunction. Its presence, particularly when linked to subdural hematomas and delayed contrast extravasation, not only reflects the immediate severity of the injury but may also indicate chronic neuroinflammatory processes and persistent cognitive deficits. In this review, we gather current evidence on the pathophysiology of TME including its associations with vascular permeability, subdural hematoma, and prolonged inflammatory responses. We explore its potential as a biomarker for injury severity and prognosis in TBI patients. Finally, we further discuss the critical need for standardized imaging protocols and longitudinal studies to determine the clinical implications of persistent TME.

Keywords: traumatic meningeal enhancement, Traumatic Brain Injury, subdural hematoma, blood-brain barrier disruption, imaging biomarkers

Received: 23 Apr 2025; Accepted: 19 Jun 2025.

Copyright: © 2025 Arbona-Lampaya, Odeh-Couvertier, Sanchez-Jimenez and Labat-Alvarez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Alejandro Arbona-Lampaya, University of Puerto Rico - School of Medicine, San Juan, Puerto Rico

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.